Home
About
Services
Partners
Client Portfolio
News
Contact
Nintendo’s Mario takes driving seat in race for mobile hit
September 24, 2019
Futures rise as Mnuchin’s comments bolster trade optimism
September 24, 2019
0
European biotech firm BioNtech plans to raise nearly $304 million in U.S. IPO
Published by
Muller&Green
at
September 24, 2019
Categories
RSS
Tags
BioNtech SE, Europe’s largest unlisted biotech firm by staff numbers, said on Tuesday that it planned to raise up to $303.6 million in an initial public offering in the United States.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more